MANH MANHATTAN ASSOCIATES INC Insider Trading

Executive Chairman Eddie Capel sold 37,342 shares of MANH for $8,296,577.01 via 7 separate transactions on 2025-07-29.

Capel executed 7 separate sales totaling 37,342 shares for $8,296,577.01 at a blended average price of $222.18, reducing his stake from 200,330 to 162,988 shares (-18.6%). This is a material liquidation by the Executive Chairman despite strong recent momentum: the stock is up 30-day (+10.9%) and up 90-day (+19.8%), trading at $219.66 yet still -29.1% below its 52-week high of $309.78. Capel's prior trades at MANH show perfect 90-day timing (5 of 5 well-timed sells), suggesting pattern recognition on his part. The company's fundamentals remain solid—$272.4M in latest quarterly revenue, $56.8M net income, and 12.2% annual revenue growth—but trades at a premium 60.02 P/E ratio on a $13.3B market cap, which may frame the motivation for a large disposition by leadership.

SVP/CLO Bruce Richards sold 4,150 shares ($1.2M) at avg $289.73 on 2024-11-29; retains 22,086 shares.

Richards executed 3 separate sales totaling 4,150 shares for $1,202,395.85 on a single day, reducing his stake by 15.8% to 22,086 shares post-transaction. The blended average sale price of $289.73 falls within the stock's 52-week range ($199.37–$304.64) and modestly below the current price of $297.09, reflecting a near-peak execution in a stock up +15.7% over the past 90 days. His prior trade timing at MANH has been inconsistent: his prior 5 trades at this ticker show only 1 well-timed outcome at the 90-day horizon, with mixed results ranging from +12.7% to -16.1% in 90-day performance. The company's strong fundamentals—$266.7M quarterly revenue, +21.1% annual growth, and $63.8M net income—sit alongside a high valuation of 82.75 P/E, which may have provided context for the sale but does not itself explain timing or motivation.

EVP Gantt James Stewart sells 3,475 shares at $288.10 average for $1,001,138.10 at MANH; retains 42,812 shares post-sale.

Gantt James Stewart executed two separate sales on 2024-11-26, totaling 3,475 shares for $1,001,138.10, reducing his holdings by 7.5% to 42,812 shares. The blended sale price of $288.10 sits above the current price of $285.44 and well above the 30-day (+7.4%) and 90-day (+8.0%) momentum context. At the same-ticker level, his prior three sales at MANH show mixed timing outcomes: the most recent 2024-07-30 sale was followed by positive returns (30d +2.7%, 90d +7.4%), while the 2024-03-05 sale preceded declines (30d -3.5%, 90d -14.5%), leaving only 1 of 3 prior MANH sales well-timed at the 90-day mark. The stock trades near its 52-week peak range ($199.37–$304.64, current -6.3% from high) with elevated valuation (P/E 79.51) despite strong fundamentals: revenue growth +21.1% year-over-year and net income of $63.8M on $266.7M in quarterly revenue. The sale appears consistent with profit-taking near a local peak rather than a directional market signal.

Richards Bruce (SVP, CLO & Secretary) sold 4,000 shares in MANH at $261.00 on 2024-08-28/29 ($1.0M)

Richards Bruce executed 2 separate sales totaling 4,000 shares for $1,044,000.00 at a blended average price of $261.00, reducing his holdings by 13.2% from 30,236 to 26,236 shares. The stock was trading near 52-week highs at the time of sale (current price $264.43, -0.6% from the $266.03 52-week high), and has appreciated 3.5% in the 30 days and 20.4% in the 90 days since the filing date. Examining his same-ticker sale history at MANH, 1 of 3 prior sales was well-timed at the 90-day mark; the most recent sale on 2024-03-06 was poorly timed with subsequent -4.8% and -16.1% returns at 30 and 90 days respectively. The current sale occurred during a strong uptrend in the stock, and the stock's continued strength post-transaction (up 3.5% in 30 days) offers no clear signal yet of insider foresight regarding near-term direction.

EVP James Stewart sold 6,000 MANH shares at $256.50 (down 4.0% from 52-week high); post-sale holdings 46,287 shares.

James Stewart, EVP of Professional Services, sold 6,000 shares (11.5% of his pre-transaction holdings) on 2024-07-30 as MANHATTAN ASSOCIATES stock trades near its 52-week high. The sale comes after the stock has appreciated 4.1% in the prior 30 days and 22.3% in the prior 90 days. His same-ticker history is mixed: a prior sell on 2024-03-05 resulted in a 90-day decline of -14.5%, while a sell on 2023-05-01 saw a 90-day gain of +10.3%, with a 50% well-timed rate across his two prior sales at MANH. The company reports strong fundamentals (21.1% annual revenue growth, $265.3M latest-quarter revenue) but commands a high P/E of 76.46. The timing and magnitude of this sale merit observation against the backdrop of sustained momentum and current valuation multiples.